Literature DB >> 1901964

Central ventilatory effects of thyrotropin-releasing hormone in the conscious rat.

S Vonhof1, A L Sirén, G Z Feuerstein.   

Abstract

Thyrotropin-releasing hormone was shown to exert potent ventilatory effects after central administration. These data, however, were derived from studies using anesthetized animal preparations. Since TRH elicits strong arousal reactions, the observed ventilatory effects of TRH under anesthesia may have been due to nonspecific reduction in the anesthetic state of the animals. In order to clarify the extent to which the reversal of anesthesia may change ventilatory parameters after TRH application, we investigated the effect of TRH on ventilation rate, relative tidal volume, relative respiratory minute volume, CO2 production CO2 consumption, and locomotor activity in the conscious, unrestrained rat. Intracerebroventricular application of TRH induced a dose-dependent, sustained increase in ventilation rate, relative tidal volume, and relative respiratory minute volume of maximally 128%, 890%, and 235%, respectively. In addition, CO2 production and O2 consumption were elevated by 4.6 and 11.7 fold, while no significant changes in locomotor activity were observed. The results suggest that TRH stimulates ventilation by a mechanism independent of its analeptic properties.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901964     DOI: 10.1016/0143-4179(91)90007-6

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  2 in total

1.  The pre-Bötzinger complex participates in generating the respiratory effects of thyroliberin.

Authors:  A N Inyushkin; N A Merkulova; S A Chepurnov
Journal:  Neurosci Behav Physiol       Date:  1999 May-Jun

Review 2.  Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?

Authors:  Marieke Hyke Algera; Joseph F Cotten; Monique van Velzen; Marieke Niesters; Martijn Boon; Daniel S Shoham; Kaye E Dandrea; Rutger van der Schrier; Albert Dahan
Journal:  Pharmacol Res Perspect       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.